DUBLIN--(BUSINESS WIRE)--The "Global Transcatheter Mitral Valve Repair & Replacement (TMVR) Market: Industry Analysis & Outlook (2018-2022)" report has been added to ResearchAndMarkets.com's offering.
Global TMVR Market: Industry Analysis & Outlook (2018-2022) provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S. and Europe region along with the global market.
Europe is a major contributor to the global TMVR market supported by increased aging and obese population, better accessibility and favorable reimbursement policies for TMVR. The U.S. is also expecting a high growth rate in TMVR market due to rising development of TMVR devices and incidences of heart diseases.
The global TMVR market is expected to grow in future due to increasing aging population, obese population, rising healthcare expenditure and economic growth. Key trends of this market include leading causes of death in the U.S., factors affecting the development of TMVR devices, prevalence of mitral regurgitation by age group in the U.S. and growing adoption of minimally invasive therapies. However, there are some factors which can hinder the market growth including associated high risks and tough regulatory problems.
The report profiles the key players of the market including Medtronic plc, Abbott Laboratories, Edwards and LivaNova Plc.
Key Topics Covered:
2. Global TMVR Market Analysis
3. Regional Market Analysis
4. Market Dynamics
6. Company Profiles
- Abbott Laboratories
- Edwards Lifesciences
- LivaNova Plc
- Medtronic Plc.
For more information about this report visit https://www.researchandmarkets.com/research/77jmnc/global?w=4